Antonio Coluccia

A. Coluccia, R. Silvestri, G. La Regina, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection

O. Turriziani, A. Coluccia, R. Silvestri, 2023, Circulation research.

3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.

A. Coluccia, A. Brancale, R. Silvestri, 2017, ACS medicinal chemistry letters.

Looking for an Active Conformation of the Future HIV Type-1 Non-Nucleoside Reverse Transcriptase Inhibitors

A. Coluccia, R. Silvestri, G. L. Regina, 2010, Antiviral chemistry & chemotherapy.

Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents.

E. Novellino, S. Taliani, C. Martini, 2015, Journal of medicinal chemistry.

Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus.

A. Coluccia, A. Brancale, R. Silvestri, 2013, Antiviral research.

Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies.

C. Martini, A. Coluccia, R. Silvestri, 2019, European journal of medicinal chemistry.

New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer.

E. Novellino, L. Di Marcotullio, C. Martini, 2015, Journal of medicinal chemistry.

New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer.

E. Novellino, L. Di Marcotullio, A. Brancale, 2014, Journal of medicinal chemistry.

Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.

Y. Ni, E. Novellino, B. Maresca, 2013, Journal of medicinal chemistry.

Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.

Ettore Novellino, Andrea Brancale, Ilaria Granata, 2011, Journal of medicinal chemistry.

New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies.

E. Novellino, B. Maresca, A. Coluccia, 2009, Journal of medicinal chemistry.

In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses

C. Lacroix, A. Coluccia, R. Silvestri, 2015, Virology Journal.

Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide.

E. Novellino, C. Pannecouque, A. Coluccia, 2011, Journal of medicinal chemistry.

Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics

Antonio Coluccia, Marianna Bufano, Marion Laudette, 2020, Journal of Computer-Aided Molecular Design.

Arylthioindoles, potent inhibitors of tubulin polymerization.

Andrea Brancale, Ernest Hamel, Antonio Coluccia, 2004, Journal of medicinal chemistry.

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy

I. Fournier, A. Coluccia, R. Silvestri, 2018, Oncogene.

Exploring CCRL2 chemerin binding using accelerated molecular dynamics

D. Raimondo, A. Coluccia, R. Silvestri, 2022, Proteins.

4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells

C. Supuran, R. Silvestri, G. La Regina, 2023, Journal of medicinal chemistry.

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.

A. Coluccia, A. Brancale, R. Silvestri, 2013, Future medicinal chemistry.

Nox2‐mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin

A. Coluccia, R. Silvestri, F. Violi, 2019, Biochemical pharmacology.

S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis☆

A. Higginbottom, A. Coluccia, A. Brancale, 2013, Free radical biology & medicine.